CO5550462A2 - Derivados de dolastatina 10 - Google Patents
Derivados de dolastatina 10Info
- Publication number
- CO5550462A2 CO5550462A2 CO04003736A CO04003736A CO5550462A2 CO 5550462 A2 CO5550462 A2 CO 5550462A2 CO 04003736 A CO04003736 A CO 04003736A CO 04003736 A CO04003736 A CO 04003736A CO 5550462 A2 CO5550462 A2 CO 5550462A2
- Authority
- CO
- Colombia
- Prior art keywords
- amino
- dioxolyl
- alkyl
- alkoxy
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1.- Un compuesto de la fórmula (I),en dondeR1, R2 y R3 son cada uno independientemente hidrógeno o(C1-C4)-alquilo;R4 es hidrógeno;alquilo sustituido opcionalmente con uno a tres sustituyentes seleccionados del grupo consistente en hidroxilo, alcoxilo, amino, mono- o di-alquilamino, carboxilo, alcoxicarbonilo, carbamoiloxilo, alquilcarboniloxilo, carbamoilo, o halógeno; alquenilo; alquinilo;(C3-C7)-cicloalquilo;arilo sustituido opcionalmente con uno a tres sustituyentes seleccionados del grupo consistente en halógeno, alcoxicarbonilo, carbamoilo, sulfamoilo, alquil-carboniloxilo,ciano, rnono- o di-alquilamino, alquilo, alcoxilo, fenilo, fenoxilo, trifluorometilo, trifluorometoxilo, tioalquilo, hidroxilo, alquilcarbonil-amino, heterociclilo, 1,3-dioxolilo, 1,4-dioxolilo, amino o bencilo; aralquilo con el grupo arilo sustituido opcionalmente con uno a tres sustituyentes seleccionados del grupo consistente en halógeno, alcoxicarbonilo, sulfamoílo, alquilcarboniloxilo, ciano, mono- o di-alquil-amino, alquilo, alcoxilo, fenilo, fenoxilo, trifluorometilo, trifluoro-metoxilo, tioalquilo, hidroxilo, alquilcarbonilamino, heterociclilo, 1,3-dioxolilo, 1,4-dioxolilo, amino o bencilo; oheterociclilalquilo;R5 es (C1-C6)-alquilamino; hidroxilo;(C3-C7)-cicloalquilamino sustituido opcionalmente por fenilo o bencilo;arilamino;aralquilamino con (C1-C4)-alquileno y el grupo arilo sustituido opcionalmente con uno a tres sustituyentes seleccionados del grupo consistente en halógeno, alcoxicarbonilo, sulfamoilo, alquilcarboniloxilo, carbamoiloxilo, ciano, mono- o di-alquilamino, alquilo, alcoxilo, fenilo, fenoxilo, trifluorometilo, trifluorometoxilo, tioalquilo, hidroxilo, alquilcarbonil-amino, heterociclilo, 1,3-dioxolilo, 1,4-dioxolilo, amino o bencilo;(C1-C4)-alcoxilo; benzhidrazino; ...
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01117410 | 2001-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5550462A2 true CO5550462A2 (es) | 2005-08-31 |
Family
ID=8178073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04003736A CO5550462A2 (es) | 2001-07-19 | 2004-01-20 | Derivados de dolastatina 10 |
Country Status (30)
Country | Link |
---|---|
US (1) | US6737409B2 (es) |
EP (1) | EP1412328B1 (es) |
JP (1) | JP2004534859A (es) |
KR (2) | KR100611540B1 (es) |
CN (1) | CN1553897A (es) |
AR (1) | AR036175A1 (es) |
AT (1) | ATE341537T1 (es) |
BR (1) | BR0211289A (es) |
CA (1) | CA2453987A1 (es) |
CO (1) | CO5550462A2 (es) |
DE (1) | DE60215179T2 (es) |
DK (1) | DK1412328T3 (es) |
ES (1) | ES2272763T3 (es) |
GT (1) | GT200200154A (es) |
HR (1) | HRP20040043A2 (es) |
HU (1) | HUP0401253A2 (es) |
IL (1) | IL159890A0 (es) |
MX (1) | MXPA04000577A (es) |
MY (1) | MY127718A (es) |
NO (1) | NO20040198L (es) |
NZ (1) | NZ530655A (es) |
PA (1) | PA8551001A1 (es) |
PE (1) | PE20030258A1 (es) |
PL (1) | PL367682A1 (es) |
PT (1) | PT1412328E (es) |
RU (1) | RU2296750C2 (es) |
SI (1) | SI1412328T1 (es) |
UY (1) | UY27388A1 (es) |
WO (1) | WO2003008378A1 (es) |
ZA (1) | ZA200400334B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7256257B2 (en) | 2001-04-30 | 2007-08-14 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
US7064211B2 (en) | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
WO2003082268A2 (en) | 2002-03-22 | 2003-10-09 | Eisai Co. Ltd | Hemiasterlin derivatives and uses thereof in the treatment of cancer |
EP2357006B1 (en) | 2002-07-31 | 2015-09-16 | Seattle Genetics, Inc. | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
EP3120861B1 (en) | 2003-11-06 | 2018-08-15 | Seattle Genetics, Inc. | Intermediate for conjugate preparation comprising auristatin derivatives and a linker |
EP1756038A1 (en) * | 2004-06-02 | 2007-02-28 | F.Hoffmann-La Roche Ag | Synthesis of amino-alkoxy-heptanoic alkyl ester |
ES2715776T3 (es) | 2004-11-12 | 2019-06-06 | Seattle Genetics Inc | Auristatinas que tienen una unidad de ácido aminobenzoico en el extremo N |
KR20070086123A (ko) * | 2004-12-13 | 2007-08-27 | 에프. 호프만-라 로슈 아게 | 하나 이상의 돌라스타틴 10 유도체를 포함하는 신규 약학조성물 |
MX2007006746A (es) * | 2004-12-13 | 2007-07-09 | Hoffmann La Roche | Proceso novedoso para la manufactura de derivados del acido 3-pirrolidin-2-il-propionico. |
US20060189893A1 (en) * | 2005-01-06 | 2006-08-24 | Diamics, Inc. | Systems and methods for detecting abnormal cells |
US20060161076A1 (en) * | 2005-01-06 | 2006-07-20 | Diamics, Inc. | Systems and methods for collection of cell clusters |
MX2007008349A (es) * | 2005-01-13 | 2007-07-25 | Hoffmann La Roche | Nueva sintesis de una etapa de aminas disustituidas utiles. |
WO2006122408A1 (en) | 2005-05-18 | 2006-11-23 | Aegera Therapeutics Inc. | Bir domain binding compounds |
WO2007008603A1 (en) * | 2005-07-07 | 2007-01-18 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus |
US8871720B2 (en) * | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
US7750116B1 (en) | 2006-02-18 | 2010-07-06 | Seattle Genetics, Inc. | Antibody drug conjugate metabolites |
JP5419685B2 (ja) | 2006-05-16 | 2014-02-19 | ファーマサイエンス・インコーポレイテッド | Iapbirドメイン結合タンパク質 |
US20080003652A1 (en) * | 2006-06-28 | 2008-01-03 | Hans Iding | Novel enzymatic process for the manufacture of Boc-Dap-Oh priority to related application(s) |
SG183023A1 (en) | 2007-07-16 | 2012-08-30 | Genentech Inc | Anti-cd79b antibodies and immunoconjugates and methods of use |
RU2557319C2 (ru) | 2007-07-16 | 2015-07-20 | Дженентек, Инк. | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА ПРОТИВ CD79b И ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ПРИМЕНЕНИЯ |
CN101981055B (zh) | 2008-01-31 | 2016-03-09 | 健泰科生物技术公司 | 抗cd79b抗体和免疫偶联物及使用方法 |
ES2647927T3 (es) | 2008-03-18 | 2017-12-27 | Seattle Genetics, Inc. | Conjugados enlazadores del fármaco auriestatina |
WO2011100403A1 (en) | 2010-02-10 | 2011-08-18 | Immunogen, Inc | Cd20 antibodies and uses thereof |
EP2534170B1 (en) | 2010-02-12 | 2017-04-19 | Pharmascience Inc. | Iap bir domain binding compounds |
EP2579887B1 (de) | 2010-06-10 | 2014-11-12 | Seattle Genetics, Inc. | Neue auristatin-derivate und ihre verwendung |
ES2553874T3 (es) | 2010-09-29 | 2015-12-14 | Seattle Genetics, Inc. | N-Carboxialquil-auristatinas y su uso |
CN103764667B (zh) * | 2011-03-16 | 2017-06-20 | 西雅图基因公司 | N‑羧烷基耳他汀类及其应用 |
ES2690993T3 (es) | 2011-05-27 | 2018-11-23 | Ambrx, Inc. | Composiciones que contienen y métodos que implican derivados de dolastatina enlazados con aminoácidos no naturales y usos de los mismos |
EP2714685B1 (en) * | 2011-05-27 | 2016-10-19 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
AU2013318779B2 (en) | 2012-09-20 | 2016-07-28 | Celltrion, Inc. | Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same |
MX2016008444A (es) | 2013-12-27 | 2017-01-11 | Zymeworks Inc | Sistemas de enlace que contienen sulfonamida para conjugados de farmacos. |
WO2016049214A1 (en) | 2014-09-23 | 2016-03-31 | Genentech, Inc. | METHOD OF USING ANTI-CD79b IMMUNOCONJUGATES |
CN105949277B (zh) * | 2015-05-05 | 2019-03-01 | 成都永泰诺科技有限公司 | 一种抗肿瘤化合物及其用途 |
PT3438118T (pt) * | 2016-03-29 | 2023-06-07 | Toray Industries | Derivado de peptídeo e utilização deste |
CN109021065B (zh) * | 2017-06-08 | 2021-10-01 | 复旦大学 | 一种制备海兔毒素Dolastatin10的方法 |
WO2023033129A1 (ja) | 2021-09-03 | 2023-03-09 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6323315B1 (en) | 1999-09-10 | 2001-11-27 | Basf Aktiengesellschaft | Dolastatin peptides |
-
2002
- 2002-07-15 US US10/195,698 patent/US6737409B2/en not_active Expired - Fee Related
- 2002-07-17 KR KR1020047000854A patent/KR100611540B1/ko not_active IP Right Cessation
- 2002-07-17 BR BR0211289-2A patent/BR0211289A/pt not_active IP Right Cessation
- 2002-07-17 NZ NZ530655A patent/NZ530655A/en unknown
- 2002-07-17 PL PL02367682A patent/PL367682A1/xx not_active Application Discontinuation
- 2002-07-17 EP EP02764710A patent/EP1412328B1/en not_active Expired - Lifetime
- 2002-07-17 WO PCT/EP2002/007931 patent/WO2003008378A1/en active IP Right Grant
- 2002-07-17 IL IL15989002A patent/IL159890A0/xx unknown
- 2002-07-17 UY UY27388A patent/UY27388A1/es not_active Application Discontinuation
- 2002-07-17 AT AT02764710T patent/ATE341537T1/de not_active IP Right Cessation
- 2002-07-17 HU HU0401253A patent/HUP0401253A2/hu unknown
- 2002-07-17 KR KR1020067008692A patent/KR20060057652A/ko not_active Application Discontinuation
- 2002-07-17 PT PT02764710T patent/PT1412328E/pt unknown
- 2002-07-17 MY MYPI20022704A patent/MY127718A/en unknown
- 2002-07-17 MX MXPA04000577A patent/MXPA04000577A/es active IP Right Grant
- 2002-07-17 SI SI200230447T patent/SI1412328T1/sl unknown
- 2002-07-17 DE DE60215179T patent/DE60215179T2/de not_active Expired - Fee Related
- 2002-07-17 DK DK02764710T patent/DK1412328T3/da active
- 2002-07-17 RU RU2004105145/04A patent/RU2296750C2/ru not_active IP Right Cessation
- 2002-07-17 CA CA002453987A patent/CA2453987A1/en not_active Abandoned
- 2002-07-17 CN CNA028177622A patent/CN1553897A/zh active Pending
- 2002-07-17 AR ARP020102678A patent/AR036175A1/es not_active Application Discontinuation
- 2002-07-17 ES ES02764710T patent/ES2272763T3/es not_active Expired - Lifetime
- 2002-07-17 JP JP2003513938A patent/JP2004534859A/ja active Pending
- 2002-07-18 GT GT200200154A patent/GT200200154A/es unknown
- 2002-07-18 PA PA20028551001A patent/PA8551001A1/es unknown
- 2002-07-19 PE PE2002000643A patent/PE20030258A1/es not_active Application Discontinuation
-
2004
- 2004-01-15 ZA ZA2004/00334A patent/ZA200400334B/en unknown
- 2004-01-16 NO NO20040198A patent/NO20040198L/no not_active Application Discontinuation
- 2004-01-19 HR HR20040043A patent/HRP20040043A2/hr not_active Application Discontinuation
- 2004-01-20 CO CO04003736A patent/CO5550462A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5550462A2 (es) | Derivados de dolastatina 10 | |
ECSP034932A (es) | Derivados de tetrahidroquinolina | |
PE20050652A1 (es) | Mezclas que contienen estrobilurinas y moduladores de etileno | |
AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
PE20050615A1 (es) | Derivados de 2-cianobencenosulfonamidas | |
AR044749A1 (es) | Inhibidor de la arn polimerasa dependiente de arn del virus de la hepatitis c y composiciones y tratamientos que lo usan | |
AR055619A1 (es) | Diaminopirimidinas como moduladores p2x2/3 | |
AR015262A1 (es) | Derivados biocidas de bencilbifenilo, composicion biocida, procedimiento para preparar dicha composicion biocida, uso de dicho compuesto para controlar microorganismos, metodo para controlar microorganismos y procedimiento para preparar dicho compuesto | |
AR039665A1 (es) | Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa | |
AR055606A1 (es) | Derivados de benzoquinazolina | |
PE20040688A1 (es) | Inhibidores de quinasas | |
TR200003752T2 (tr) | Sinerjik etkili herbisit karışımlar | |
CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
AR038717A1 (es) | Ciclopropil-azol-carboxamidas | |
ECSP055815A (es) | Composición para el tratamiento de la infección por virus flaviviridae | |
NO20062339L (no) | Hepatitt C virus-inhibitoerer | |
NO20044807L (no) | Heratitt C virus inhibitorer | |
CR8505A (es) | Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad | |
AR038019A1 (es) | Naftalenos substituidos con fenilo como agentes estrogenicos | |
AR054214A1 (es) | Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c. | |
ES2531149T3 (es) | Derivados de 2-piridiniletilcarboxamida y su uso como fungicidas | |
CO5580747A2 (es) | Derivados e intermediarios de n-adamantilmetilo como composiciones farmaceuticas y procesos para su preparacion | |
NO20054340L (no) | Nye sammenkoplede heterocykler og deres anvendelse | |
AR046943A1 (es) | Derivados de 2-piridiniletilbenzamida, un procedimiento para su preparacion, composiciones fungicidas que lo contienen y su uso en el control de hongos fitopatogenos | |
DK1539734T3 (da) | Quinolylpropylpiperidinderivater og deres anvendelse som antimikrobielle midler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |